Agilon Health Inc. (AGL) Tops Q1 EPS by 2c; maintains guidance

Agilon Health Inc. (NYSE: AGL) reported Q1 EPS of $0.01, $0.02 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.61 billion.

GUIDANCE:

Agilon Health Inc. sees Q2 2024 revenue of $1.55-1.57 billion, versus the consensus of $1.6 billion.

Agilon Health Inc. sees FY2024 revenue of $6.125-6.175 billion, versus the consensus of $6.396 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• AeroVironment restates quarterly financials, citing $89M goodwill error